Jerusalem, Israel

Eytan Klausner

This inventor holds 1 USPTO granted patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eytan Klausner: Innovator in Gastroretentive Drug Delivery Systems

Introduction

Eytan Klausner is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of gastroretentive drug delivery systems. His innovative approach aims to enhance the effectiveness of drug administration by controlling the release of active agents in the gastrointestinal tract.

Latest Patents

Klausner holds a patent for "Gastroretentive controlled release pharmaceutical dosage forms." This patent describes pharmaceutical gastroretentive drug delivery systems designed for the controlled release of an active agent. The system comprises a matrix made from various polymers that ensure the delivery system remains in the stomach for a specified duration, ranging from about 3 to about 24 hours. This advancement has the potential to improve therapeutic outcomes for patients requiring sustained medication.

Career Highlights

Eytan Klausner is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to collaborate with leading researchers and contribute to groundbreaking innovations in drug delivery systems. His expertise in polymer science and drug formulation has positioned him as a key figure in pharmaceutical research.

Collaborations

Klausner has worked alongside notable colleagues, including Michael M. Friedman and Eran Lavy. These collaborations have fostered a dynamic research environment, leading to advancements in the field of controlled drug release technologies.

Conclusion

Eytan Klausner's contributions to gastroretentive drug delivery systems exemplify the importance of innovation in pharmaceuticals. His work not only enhances drug efficacy but also paves the way for future advancements in medication administration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…